Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CRISPR Therapeutics AG | 15,565 | reported | 23 Mar 2026 | tx 45+529,045−212,529 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 6,250 | — | |
| 23 Mar 2026 | SALE | CRISPR Therapeutics AG | 3,708 | 46.78 USD | |
| 20 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 6,250 | — | deriv |
| 20 Mar 2026 | GRANT_AWARD | CRISPR Therapeutics AG | 38,499 | 0.00 USD | deriv |
| 20 Mar 2026 | GRANT_AWARD | CRISPR Therapeutics AG | 27,500 | 0.00 USD | deriv |
| 16 Mar 2026 | SALE | CRISPR Therapeutics AG | 5,848 | 48.26 USD | |
| 16 Mar 2026 | GIFT | CRISPR Therapeutics AG | 750 | 0.00 USD | |
| 14 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 6,875 | — | |
| 14 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 10,000 | — | |
| 16 Mar 2026 | SALE | CRISPR Therapeutics AG | 4,021 | 48.26 USD | |
| 14 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 6,875 | — | deriv |
| 14 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 10,000 | — | deriv |
| 22 Jan 2026 | EXERCISE | CRISPR Therapeutics AG | 34,972 | 45.15 USD | |
| 22 Jan 2026 | SALE | CRISPR Therapeutics AG | 34,972 | 60.19 USD | anomaly |
| 22 Jan 2026 | EXERCISE | CRISPR Therapeutics AG | 34,972 | 0.00 USD | deriv |
| 06 Jan 2026 | EXERCISE | CRISPR Therapeutics AG | 23,361 | 45.15 USD | |
| 06 Jan 2026 | EXERCISE | CRISPR Therapeutics AG | 6,339 | 44.31 USD | |
| 06 Jan 2026 | SALE | CRISPR Therapeutics AG | 5,763 | 60.21 USD | |
| 06 Jan 2026 | SALE | CRISPR Therapeutics AG | 5,004 | 60.00 USD | |
| 06 Jan 2026 | SALE | CRISPR Therapeutics AG | 18,933 | 60.18 USD | |
| 06 Jan 2026 | EXERCISE | CRISPR Therapeutics AG | 23,361 | 0.00 USD | deriv |
| 06 Jan 2026 | EXERCISE | CRISPR Therapeutics AG | 6,339 | 0.00 USD | deriv |
| 22 Dec 2025 | SALE | CRISPR Therapeutics AG | 3,528 | 55.10 USD | |
| 22 Dec 2025 | SALE | CRISPR Therapeutics AG | 1,000 | 56.89 USD | |
| 22 Dec 2025 | SALE | CRISPR Therapeutics AG | 5,472 | 56.33 USD |